Cart
sales@molnova.com
Home - Products - Angiogenesis - VEGFR - GW297361

GW297361

CAS No. 388627-21-2

GW297361( —— )

Catalog No. M36628 CAS No. 388627-21-2

GW297361 is a potent inhibitor of the cell cycle protein-dependent kinase Cdk1 and also inhibits the Pho85 signaling pathway.The IC50s of GW297361 on yeast Cdk1 and Pho85 were 20 nM and 400 nM, respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 375 Get Quote
5MG 588 Get Quote
10MG 885 Get Quote
25MG 1362 Get Quote
50MG 1822 Get Quote
100MG 2457 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    GW297361
  • Note
    Research use only, not for human use.
  • Brief Description
    GW297361 is a potent inhibitor of the cell cycle protein-dependent kinase Cdk1 and also inhibits the Pho85 signaling pathway.The IC50s of GW297361 on yeast Cdk1 and Pho85 were 20 nM and 400 nM, respectively.
  • Description
    GW297361 is an oxindole CDK inhibitor that elicits a Pho85-selective response in cells. GW297361 inhibits yeast Cdk1 and Pho85 with IC50s of 20 nM and 400 nM in vitro, respectively.
  • In Vitro
    Western Blot Analysis Cell Line:YRP1 cells Concentration:20 μM Incubation Time:20 μM Result:An intermediate level of the Orc6 was converted to the faster-migrating isoform (lower:upper = 2:1).
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    VEGFR
  • Recptor
    VEGFR | Src | CDK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    388627-21-2
  • Formula Weight
    372.42
  • Molecular Formula
    C16H12N4O3S2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (268.51 mM; Ultrasonic )
  • SMILES
    C(NC1=CC=C(S(N)(=O)=O)C=C1)=C2C=3C4=C(C=CC3NC2=O)N=CS4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kung C, et al. Selective kinase inhibition by exploiting differential pathway sensitivity. Chem Biol. 2006 Apr;13(4):399-407.?
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Ellipticine

    Ellipticine is a potent antineoplastic agent exhibiting multiple mechanisms of action.

  • Tivozanib

    A highly potent inhibitor of pan-VEGFR with IC50s of 60/6.5/15 nM for VEGFR1/2/3.

  • Vatalanib

    A potent, orally available class III receptor tyrosine kinases inhibitor with IC50 of <1 uM for VEGFR, Flt-1, KDR and PDGFRβ.

Sign In Join Free